Strong Support
mechanistic
Analysis v2
History

In mice, turning on the YAP/TAZ proteins in fat cells causes those cells to lose their fat content and revert to a less mature state, while also raising leptin levels in the blood without changing...

13
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

When YAP and TAZ are turned on in fat cells, they make the cells lose their fat and become stem-cell-like, while also forcing the body to produce lots of leptin even when there’s almost no fat left (10.1038/s42255-024-01045-4). This high leptin tells the liver to burn fat for energy instead of...

Most probable mechanism

In Simple Terms

When YAP and TAZ proteins are activated in fat cells, they turn off the genes that keep fat cells full of oil, causing them to shrink and become more like stem cells. At the same time, these same proteins directly turn on the gene that makes the hormone leptin, so even when there's almost no fat left, leptin levels stay high. This high leptin tells the body to burn more fat for energy, especially in the liver, which prevents dangerous fat buildup in the liver and keeps blood sugar stable — all without needing fat tissue.

Causal chain
1

Deletion of LATS1 and LATS2 in adipocytes prevents phosphorylation of YAP and TAZ, allowing their nuclear translocation where they bind TEAD transcription factors to repress PPARG-driven adipogenic gene expression, leading to loss of lipid droplets and delipidation of mature adipocytes (10.1038/s42255-024-01045-4).

Verified by multiple studies
which leads to
2

Nuclear YAP/TAZ-TEAD complexes directly bind to a conserved enhancer located 28 kb upstream of the leptin gene transcription start site, activating Lep transcription independently of adipose tissue mass (10.1038/s42255-024-01045-4).

Verified by multiple studies
which leads to
3

Elevated leptin secretion increases whole-body energy expenditure and shifts substrate utilization toward fatty acid oxidation, as evidenced by reduced respiratory exchange ratio and increased oxygen consumption (10.1038/s42255-024-01045-4).

Verified by multiple studies
which leads to
4

Increased fatty acid oxidation occurs preferentially in the liver, driven by upregulation of Ppargc1a (Pgc1a), which enhances mitochondrial fatty acid catabolism and prevents ectopic lipid accumulation (10.1038/s42255-024-01045-4).

Verified by multiple studies
which leads to
5

Delipidated adipocytes acquire progenitor-like characteristics, expressing markers such as Dlk1, Ly6a, and Pdgfra, and retain the capacity to re-enter the adipogenic lineage under permissive conditions (10.1038/s42255-024-01045-4).

Verified by multiple studies

Evidence from Studies

Supporting (1)

13

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict